Literature DB >> 8840093

The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness.

S R Heller1, I A Macdonald.   

Abstract

The risk of hypoglycaemia and the resulting impairment in brain function are major factors preventing those with diabetes achieving normoglycaemia. The need to define these risks more precisely has prompted an increasing research effort to identify which aspects of cerebral function are particularly vulnerable and at which glucose level. Much of the evidence is inconsistent, reflecting not only the wide range of methods for measuring cognitive function and inducing hypoglycaemia, but also the inherent variability of the response. Nevertheless, the data suggest that those mental activities which are relatively undemanding are often unaffected at all levels of experimental hypoglycaemia while the performance of more complex tasks deteriorates at glucose concentrations of around 3 mmol l-1. The relative imprecision of cognitive testing is reflected in the debate which surrounds the pathogenesis of hypoglycaemia unawareness. There is some evidence that the glycaemic threshold for autonomic activation and symptoms can vary while the threshold for cognitive impairment is fixed. This has led to the hypothesis that hypoglycaemia unawareness arises when the autonomic response develops at a blood glucose below that for impaired cognition, thus preventing patients from recognizing or responding to their usual symptoms. However, contradictory data suggest that the threshold for cognitive impairment can alter in line with the autonomic response, a conclusion which falls to fit either the above hypothesis or the clinical description of hypoglycaemia unawareness. These differences may be methodological or relate to the relative imprecision of measurements of cognitive function. Resolution of these discrepancies may have to await the development of advanced technology such as high resolution MRI or PET scanning. In the meantime, progress could be made if all groups agreed on a limited range of cognitive function tests and used them in a standardized manner.

Entities:  

Mesh:

Year:  1996        PMID: 8840093     DOI: 10.1002/(SICI)1096-9136(199607)13:7<607::AID-DIA159>3.0.CO;2-I

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set.

Authors:  Roy W Beck; Richard M Bergenstal; Tonya D Riddlesworth; Craig Kollman
Journal:  Diabetes Technol Ther       Date:  2018-12-21       Impact factor: 6.118

2.  Impaired driving from medical conditions: a 70-year-old man trying to decide if he should continue driving.

Authors:  Matthew Rizzo
Journal:  JAMA       Date:  2011-03-01       Impact factor: 56.272

Review 3.  4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.

Authors:  Marzia Perluigi; Raffaella Coccia; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2012-02-15       Impact factor: 8.401

4.  The effects of acute hypoglycaemia on memory acquisition and recall and prospective memory in type 1 diabetes.

Authors:  R E Warren; N N Zammitt; I J Deary; B M Frier
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

5.  The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia.

Authors:  D Smith; A Pernet; J M Rosenthal; E M Bingham; H Reid; I A Macdonald; S A Amiel
Journal:  Diabetologia       Date:  2004-10-23       Impact factor: 10.122

6.  Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial).

Authors:  Stuart Little; Thomas Chadwick; Pratik Choudhary; Cath Brennand; Julia Stickland; Shalleen Barendse; Tolulope Olateju; Lalantha Leelarathna; Emma Walkinshaw; Horng K Tan; Sally M Marshall; Reena M Thomas; Simon Heller; Mark Evans; David Kerr; Daniel Flanagan; Jane Speight; James Am Shaw
Journal:  BMC Endocr Disord       Date:  2012-12-13       Impact factor: 2.763

7.  Moderate Recurrent Hypoglycemia Markedly Impairs Set-Shifting Ability in a Rodent Model: Cognitive and Neurochemical Effects.

Authors:  Vaishali Jahagirdar; Justin Ramcharitar; Victoria E Cotero; Ewan C McNay
Journal:  Open Diabetes J       Date:  2012

8.  Beyond A1C-Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve.

Authors:  Roy W Beck; Richard M Bergenstal
Journal:  Diabetes Spectr       Date:  2021-05-25

9.  Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.

Authors:  Lalantha Leelarathna; Stuart A Little; Emma Walkinshaw; Horng Kai Tan; Alexandra Lubina-Solomon; Kavita Kumareswaran; Annette P Lane; Thomas Chadwick; Sally M Marshall; Jane Speight; Daniel Flanagan; Simon R Heller; James A M Shaw; Mark L Evans
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

10.  Acute hypoglycemia impairs executive cognitive function in adults with and without type 1 diabetes.

Authors:  Alex J Graveling; Ian J Deary; Brian M Frier
Journal:  Diabetes Care       Date:  2013-06-18       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.